LMT
52
2
BIIB
45
-3
FFIV
64
2
AZO
45
2
GOOG
75
2
CHRW
56
2
EMC
85
38
MPC
44
5
CHD
62
-2
DD
67
6
GME
75
-14
BK
74
3
PSA
48
2
ADP
68
2
HST
39
-5
CAH
43
2
FOX
50
2
RSG
67
2
HOG
29
-10
NVDA
60
-3
LMT
52
2
BIIB
45
-3
FFIV
64
2
AZO
45
2
GOOG
75
2
CHRW
56
2
EMC
85
38
MPC
44
5
CHD
62
-2
DD
67
6
GME
75
-14
BK
74
3
PSA
48
2
ADP
68
2
HST
39
-5
CAH
43
2
FOX
50
2
RSG
67
2
HOG
29
-10
NVDA
60
-3
Financhill
Back

Kezar Life Sciences 10K Form

Sell
24

KZR
Kezar Life Sciences

Last Price:
0.76
Seasonality Move:
-9.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KZR News And Ratings

See the #1 stock for the next 7 days that we like better than KZR

KZR Financial Statistics

Sales & Book Value

Annual Sales: $7M
Cash Flow: $-22.86M
Price / Cash Flow: 0
Annual Sales: $2.32
Price / Book: 0.33

Profitability

EPS (TTM): -1.40000
Net Income (TTM): $-101.33M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Kezar Life Sciences Earnings Forecast

Key Kezar Life Sciences Financial Ratios

  • The Research & Development expenses have been 1,224.24% of Revenue.
  • The Interest Expense is -1.52% of Operating Income.
  • The Net Earning history of KZR is -1,455.29% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Kezar Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KZR
CUSIP: 49372L
Website: kezarlifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KZR Technical Analysis vs Fundamental Analysis

Sell
24
Kezar Life Sciences (KZR) is a Sell

Is Kezar Life Sciences a Buy or a Sell?